Tags
You are here: Home
E&Y
Welcome To Pharma 3.0
Metamorphosis - In our first article in the Welcome to Pharma 3.0 series, "A New Business Model for Delivering Sustained Value," (CHEManager Europe 2-3/2010), we described how the industry's legacy business 1.0 model, based on marketing blockbuster drugs, is currently morphing into a more diversified 2.0 model. more
Welcome to Pharma 3.0
Evolution - Today more than ever before, the pharmaceutical industry can rely on solid fundamentals for growth. A steadily growing and aging world population is expanding the industry's base of potential patients, and rising incomes in emerging economies are contributing to increased demand for pharmaceutical products. However, the industry faces many pressure points, from pricing and regulatory hurdles to patent expirations, thinning drug pipelines and efficacy issues. more- Legal
- Help
- Participate
- Related Publications